It was reported that the presence of tumor-infiltrating lymphocytes (TIL) is related to a favorable outcome in breast cancer patients, thus CD8+T cells are considered as a crucial determinant of favorable clinical outcomes (28). This evidence concerns the gene CD8A and neoplasm.